Healthcare Industry News Weekly Wrap-Up: December 23, 2022
// Biotech and Pharma Therapeutics Pfizer snaps up rights to RSV therapy left behind in ReViral buy for $20M December 19, 2022 / Pfizer / RSV / LianBio / Licensing Deals Pfizer, looking to be the king in respiratory syncytial...